GLP-1 Telehealth: What Prescribers Need to Know in New York

You’re a psychiatrist. You’ve built your practice around treating depression, anxiety, ADHD, bipolar disorder. Your schedule is full. You’re good at what you do.

But lately, you’ve noticed something: your patients keep asking about weight loss.

Maybe it’s the patient on olanzapine who’s gained 40 pounds and feels hopeless. Maybe it’s the string of inquiries about ‘that Ozempic drug everyone’s talking about.’ Or maybe you’ve just seen the headlines – 20 million Americans now taking GLP-1 medications, demand surging 600% in six years, and telehealth weight-loss practices printing money.

Here’s the reality: there’s a massive opportunity sitting in front of psychiatric providers right now. GLP-1 weight management isn’t some niche add-on anymore – it’s become a core patient need, and psychiatrists are uniquely positioned to meet it.

But here’s the catch: scaling a GLP-1 practice the wrong way is a fast track to burnout. Endless follow-ups. Medication troubleshooting at 9 PM. Patients expecting miracles while you’re drowning in documentation.

This guide will show you how to build a profitable, scalable GLP-1 weight-loss service line without sacrificing your sanity. We’ll cover patient acquisition (the smart way), telehealth compliance across states, workflow efficiencies that actually work, and the cash-vs-insurance economics that determine whether this venture makes financial sense.

Let’s start with the question everyone’s asking.

Why Psychiatrists Are Perfect for GLP-1 Weight Management (And Why Patients Want You)

The Psych-Weight Connection Is Real

Half of psychiatrists are already prescribing or recommending GLP-1s, according to a late-2023 survey. That’s not surprising when you consider:

• Antipsychotic-induced weight gain is one of the most distressing side effects in psychiatric treatment. Patients on medications like olanzapine, quetiapine, or risperidone routinely gain 20-50+ pounds, leading to medication non-compliance and worsening mental health.

• Depression and obesity feed each other – the bi-directional relationship is well-documented. Patients who lose weight often see mood improvements; conversely, untreated depression makes weight loss nearly impossible.

• Binge eating disorder and emotional eating overlap heavily with anxiety and mood disorders. A psychiatrist who can address both the behavioral and pharmacological aspects of weight management delivers something primary care can’t match.

You already understand behavior change. You already manage chronic medications with side effects. You already build long-term patient relationships built on trust. That’s the entire foundation of successful GLP-1 therapy.

What Makes You Different from Weight-Loss Mills

The telehealth landscape is flooded with GLP-1 subscription services – some good, many sketchy. What they lack is exactly what you bring:

Mental health expertise. When a patient on semaglutide reports feeling ‘off’ or more anxious, a family practice doc might shrug it off. You’ll recognize potential mood effects, screen appropriately, and adjust treatment. (While the FDA ultimately found no causal link between GLP-1s and suicidal ideation, psychiatrists remain vigilant about any neuropsychiatric symptoms – a value-add that sets you apart.)

Holistic treatment approach. You’re not just writing a prescription and hoping for the best. You understand motivation, self-efficacy, body image, trauma histories that influence eating behaviors. This integrated care model resonates with patients tired of fragmented healthcare.

Existing patient relationships. Many of your current patients are already candidates for GLP-1 therapy. You don’t need to spend thousands on ads to acquire new patients when you can start by serving people who already trust you.

The Market Reality: Demand Far Exceeds Supply

By 2025, an estimated 6% of Americans (20 million people) were actively taking GLP-1 medications – and that number keeps growing. Roughly 75% of Americans are overweight or obese. That’s not a niche market; that’s a tsunami of demand.

Meanwhile, there’s a critical shortage of providers equipped to manage this patient volume. Obesity medicine specialists are few and far between, and they’re swamped. Primary care physicians often lack the time or expertise for intensive weight management. Endocrinologists focus on diabetes.

This gap is your opportunity. Patients are actively searching for qualified prescribers who will take their weight struggles seriously, provide ongoing support, and help them navigate the complexities of GLP-1 therapy.

And here’s the kicker: patients expect to pay out-of-pocket for this. They’ve seen the headlines about insurance denials. They know it’s a cash-pay market. That means you’re not fighting with prior authorizations or dealing with insurance reimbursement nightmares – you’re building a direct-pay revenue stream that doesn’t depend on third-party payers.

Free consultations available with select providers only.

Grow your practice on Klarity

Free to list. Pay only for new patient bookings. Most providers see their first patient within 24 hours.

Start seeing patients

Free to list. Pay only for new patient bookings. Most providers see their first patient within 24 hours.

How to Actually Get GLP-1 Patients (Without Gambling on Marketing)

Let’s talk economics, because this is where most providers get burned.

The Marketing Reality Nobody Mentions

You’ve probably read blog posts claiming you can acquire weight-loss patients for ‘$30-50 through Facebook ads’ or ‘just optimize your SEO.’

That’s fantasy. Here’s the real math:

DIY marketing (Google Ads, SEO, directory listings) costs $200-500+ per qualified patient when you factor in everything:

• Agency/consultant fees (most solo providers don’t have in-house digital marketing expertise)
• Ad spend testing and optimization (mental health keywords cost $15-40+ per click; most clicks don’t convert)
• Staff time to handle and qualify leads (answering calls, screening out tire-kickers)
• No-show rates from cold leads (someone who clicked an ad isn’t as committed as someone pre-qualified)
• SEO takes 6-12 months of consistent investment before generating meaningful patient flow

Psychology Today and directories? Monthly fees plus fierce competition (you’re one listing among hundreds). Zocdoc charges $35-100+ per booking, plus subscription fees.

For most psychiatrists – especially those starting out or scaling – spending $3,000-5,000/month on marketing with uncertain results is a non-starter.

The Smarter Path: Platform-Based Patient Acquisition

This is where platforms like Klarity Health change the game entirely.

Instead of gambling on marketing channels, you pay only when a pre-qualified patient books with you. It’s a pay-per-appointment model (similar to Zocdoc, but purpose-built for mental health providers expanding into adjacent services).

What that means practically:

• No upfront marketing spend or monthly subscription fees bleeding your budget
• Pre-qualified patients already matched to your specialty and availability (they want weight management; they’ve been screened for basic eligibility)
• No wasted ad spend on clicks that never convert to booked appointments
• Built-in telehealth infrastructure – no need to pay separately for video platform, EHR integrations, or scheduling systems
• Both insurance and cash-pay patient flow depending on how you structure your practice
• You control your schedule – only accept patients when you have capacity; only pay when you see them

The economics are straightforward: instead of risking thousands monthly on marketing that might not work, you pay a standard listing fee per new patient lead. That’s guaranteed ROI versus gambling on Google Ads.

Leverage Your Existing Patient Base First

The lowest-cost patient acquisition is converting existing patients who already trust you.

Start by identifying current psychiatric patients who meet GLP-1 criteria:

• BMI ≥30 (obesity) or BMI ≥27 with weight-related comorbidities (hypertension, diabetes, sleep apnea, etc.)
• Patients on medications known to cause weight gain (antipsychotics, mood stabilizers, some antidepressants)
• Patients expressing frustration about weight or asking about weight-loss options

Introduce it naturally during medication reviews: ‘I notice the Seroquel has been helpful for your mood, but we should talk about the weight gain. Have you heard about the GLP-1 medications? I’m now offering that as part of our practice.’

This isn’t a hard sell. You’re addressing a real pain point your patients already have. Many will jump at the opportunity to tackle weight management with a provider who understands their mental health context.

External Acquisition: Targeted, Not Scattershot

For attracting new weight-loss patients outside your existing practice:

1. Join a reputable telehealth platform (like Klarity) that handles marketing and patient matching. This immediately connects you with high patient volume without the DIY marketing headaches.

2. SEO and content marketing – but be realistic about timelines. Create content about topics like ‘psychiatrist weight loss treatment,’ ‘GLP-1 and mental health,’ or ‘managing antipsychotic weight gain.’ This is a 6-12 month investment before meaningful traffic.

3. Build referral relationships with:

• Primary care physicians and endocrinologists (who lack bandwidth for intensive weight management)
• Therapists and dietitians (who need prescribers to partner with)
• Bariatric surgeons (many patients try medication before considering surgery)

4. Social media – share patient success stories (with permission), educational content about the psychology of weight loss, and your unique approach combining mental and metabolic health.

Frame your differentiation clearly: ‘Psychiatrist offering medical weight management’ stands out from generic weight-loss clinics. Emphasize the whole-person approach, mental health screening, and long-term behavioral support.

Telehealth Compliance: State-by-State Rules You Need to Know

GLP-1 prescribing via telehealth is broadly permitted because these medications are not controlled substances. But compliance requirements vary by state, especially for NPs and PAs.

The Federal Baseline

Ryan Haight Act: Only applies to controlled substances. GLP-1s (semaglutide, tirzepatide, liraglutide) are NOT scheduled drugs, so there’s no federal in-person exam requirement. You can prescribe entirely via telehealth.

DEA registration: Not required for GLP-1 prescribing (again, non-controlled).

Standard of care: You must conduct an adequate patient evaluation (history, assessment, informed consent) – but this can happen via synchronous video. Document appropriately.

State-Specific Licensing and Scope Rules

You must be licensed in the patient’s state. This is non-negotiable. Here’s what that means for priority states:

California

• Physicians (MD/DO): Need full CA medical license. California is NOT in the Interstate Medical Licensure Compact (IMLC), so out-of-state docs must get full CA licensure.
• Psychiatric NPs: Must operate under physician supervision/protocol unless they’ve achieved AB 890 independent status (available starting Jan 2026 after completing 3 years as a ‘103 NP’).
• Telehealth requirements: Obtain verbal or written patient consent for telehealth. No in-person visit required for non-controlled substances.
• Insurance note: Medi-Cal (California Medicaid) covers GLP-1 for obesity as of 2024 – could increase patient interest if you accept insurance.

Texas

• Physicians: Need Texas license or use IMLC for expedited licensure (Texas is a member).
• Psychiatric NPs/PAs: Strict supervision required. Must have Prescriptive Authority Agreement with a Texas physician. One MD can supervise up to 7 APRNs/PAs.
• Telehealth rules: Patient relationship can be established via synchronous audio-visual consult (no in-person visit required). Texas Medical Board Rule 174 allows pure telehealth if standard of care is met.
• High obesity rate (~35%) and many underserved rural areas = strong patient demand.

Florida

• Physicians: Either obtain full Florida license OR use Florida’s Out-of-State Telehealth Provider Registration (lets out-of-state MDs practice telemed in FL without full licensure).
• Psychiatric NPs: Must have supervising doctor via protocol (Florida’s autonomous NP license applies only to primary care NPs, not psych NPs).
• Telehealth rules: No prior in-person exam required. GLP-1 prescribing via telehealth is fully permitted (non-controlled).
• Large market with high obesity prevalence (~30-35%), but limited insurance coverage for obesity drugs = mostly cash-pay patients.

New York

• Physicians: Need full NY license (NOT in IMLC).
• Psychiatric NPs: Experienced NPs (≥3,600 hours of practice) can operate independently under NY’s Nurse Practitioner Modernization Act. Newer NPs need collaborative agreements.
• Telehealth: No special restrictions. Strong telehealth parity laws (insurance must cover telehealth like in-person).
• Market: Huge urban population in NYC area (competition), but underserved rural regions upstate.

Pennsylvania

• Physicians: Need PA license or use IMLC (PA is a member).
• Psychiatric NPs: Must have Collaborative Agreement with a physician to prescribe. No independent NP practice in PA yet (legislative efforts stalled).
• Telehealth: No in-person requirement for non-controlled substances. PA joined Nurse Licensure Compact in 2025.
• Market: Obesity rate ~33%. Medicaid Pennsylvania began covering GLP-1 for obesity in 2024.

Illinois

• Physicians: Need Illinois license (IL is in IMLC).
• Psychiatric NPs: Can achieve Full Practice Authority (FPA) after 4,000 hours of supervised practice + 250 hours additional education. FPA-certified NPs prescribe independently.
• Telehealth: Strong telehealth parity law (insurance must cover). No in-person requirement for non-controlled substances.
• Market: Illinois Medicaid covers GLP-1 for obesity. High demand in urban centers (Chicago) and rural gaps.

Key Compliance Takeaways

1. Licensure is non-negotiable. Make sure you’re licensed in every state where your patients reside. IMLC can expedite physician licensing; look into nurse compacts for NPs.

2. Scope of practice matters. NPs and PAs need to understand their state’s supervision requirements. If you’re an NP in a restrictive state (TX, PA, FL), partner with a supervising physician or use a platform that provides this.

3. Document everything. Telehealth encounters must meet the same documentation standards as in-person. Include: patient history, physical assessment (via video – ask about vital signs if patient has home monitoring), informed consent for medication, education about side effects, follow-up plan.

4. Off-label use disclosure. If prescribing semaglutide (Ozempic) for obesity instead of the FDA-approved Wegovy, document that patient understands off-label use and consents. (Practically, this is common and legal, but documentation protects you.)

5. Pharmacy partnerships. Ensure any compounding pharmacy you work with is state-licensed and FDA-compliant. The FDA has issued warnings about questionable compounded semaglutide sources.

6. Malpractice coverage. Inform your malpractice insurer that you’re prescribing weight-loss medications. Confirm coverage extends to obesity treatment (it usually does, but verify).

The Cash-Pay vs. Insurance Decision (And Why Most Choose Cash)

This is the economics question that determines your practice model.

Why Weight-Loss Telehealth Favors Cash-Pay

Insurance coverage for GLP-1 obesity treatment is limited. As of mid-2024, only 13 state Medicaid programs (including CA, PA, IL) covered GLP-1s for weight loss. Most private insurers exclude obesity drugs or require extensive prior authorizations with strict criteria.

Many insurers cover GLP-1s for diabetes but explicitly exclude weight-loss use. Result: most patients pay out-of-pocket for the medication regardless of whether the visit is covered.

This creates a cash-pay ecosystem. Patients already expect to pay $200-500+/month for compounded semaglutide or $1,300+/month for brand Wegovy. Adding $100-200 for monthly provider visits isn’t a dealbreaker – especially if it includes comprehensive support.

Cash-Pay Practice Model

Pros:

• Simple operations – no prior authorizations, no claim denials, no insurance credentialing headaches
• Direct revenue – patients pay upfront; you control pricing
• Faster scaling – no insurance panel limitations; see as many patients as you want
• Higher margins – keep 100% of what you charge (minus platform fees if using one)

Typical structure:

• Initial consultation: $150-250
• Monthly follow-ups: $75-150
• Or subscription model: $200-300/month includes visits + medication (if you’re dispensing through partner pharmacy)

Cons:

• Limits access for lower-income patients (though many argue these patients can’t afford the medication anyway)
• Patient acquisition may skew toward higher-income demographics
• No insurance ‘legitimacy signal’ (some patients prefer practices that take insurance as a marker of credibility)

Insurance-Based Practice Model

Pros:

• Wider patient access – people with coverage can afford visits even if paying cash for meds
• Legitimacy/trust – being in-network signals you’re an ‘established’ provider
• Potential for better retention – patients less likely to drop out when visits are covered
• May qualify for certain state programs – as more Medicaid programs cover GLP-1s, you can serve that population

Typical billing:

• Use E/M codes (99213/99214 for follow-ups, 99203/99204 for new patients)
• Possibly Medicare G0447 (behavioral counseling for obesity)
• Document medical necessity (obesity + comorbidities)

Cons:

• Prior authorization hell for medications (even if visit is covered, the med likely isn’t)
• Lower reimbursement – insurance pays $80-120 for what you’d charge $150 cash-pay
• Administrative burden – credentialing, claim submission, denial management
• Panel limitations – can’t scale infinitely without becoming in-network with multiple payers

Hybrid Model (The Pragmatic Approach)

Many psychiatrists do this:

• Charge cash for initial consultation (intensive 45-60 minute evaluation not fully reimbursed by insurance)
• Bill insurance for follow-ups if patient has coverage and it’s worth your time
• Help patients with medication prior auths if they have diabetes diagnosis or comorbidities, but set expectations that most will pay cash for meds

Key principle: Be transparent with patients upfront about costs. Provide a clear breakdown:

• Visit fees (cash vs. insurance)
• Estimated medication costs (brand vs. compounded)
• Monthly total investment

Patients appreciate honesty. If you’re clear about economics from the start, they’re less likely to feel blindsided later.

Building Workflows That Scale Without Breaking You

This is where burnout prevention starts: efficient systems that let you see more patients without working more hours.

Standardize Your Intake Process

Before the first appointment, patients should complete:

• Comprehensive health history form (weight history, diet attempts, medical conditions, psychiatric history)
• Medication list and allergies
• Mental health screening (PHQ-9, GAD-7 at minimum)
• Contraindication checklist (history of pancreatitis, thyroid cancer, MEN2 syndrome, etc.)
• Informed consent for telehealth and GLP-1 therapy

Use conditional logic in forms: ‘Have you ever had pancreatitis?’ → If yes, alert provider to discuss further before prescribing.

This saves 10-15 minutes of appointment time and ensures you never miss a critical contraindication.

Create a Template for Initial Consultations

Your first visit should cover the same core elements every time:

1. Review medical/psych history (pre-filled from forms)
2. Confirm eligibility (BMI criteria, comorbidities, no contraindications)
3. Set realistic expectations (typical weight loss: 10-15% body weight over 6-12 months; not a miracle cure)
4. Discuss lifestyle modifications (diet, exercise, sleep, stress management)
5. Medication education (how GLP-1s work, injection technique, side effects)
6. Prescribe initial dose (usually start low: semaglutide 0.25mg weekly)
7. Order baseline labs (A1c, fasting glucose, lipid panel, liver enzymes, TSH if indicated)
8. Schedule follow-up (usually 1 month for dose titration)

Document using a template note with checkboxes for each element. This ensures consistency and makes charting faster.

Optimize Follow-Up Visits

Most follow-ups are brief and protocol-driven:

Typical 15-20 minute follow-up covers:

• Weight update (patient reports or uses connected scale)
• Side effects (GI upset is common early on – provide management tips)
• Tolerability (any mood changes, injection site reactions)
• Dose adjustment if needed (titrate up every 4 weeks until therapeutic dose or side effects limit)
• Brief lifestyle coaching (reinforce diet/exercise goals)
• Schedule next visit

Delegation opportunities:

• Medical assistant or RN can gather vitals, weight, and symptom questionnaire before provider joins video call
• Health coach or dietitian can handle dietary counseling separately (weekly group sessions or individual coaching)
• Automated messaging can send injection technique videos, side effect management tips, or motivational content between visits

Use Technology to Streamline

Remote patient monitoring: Connected scales that auto-sync weight data to your EHR. You can review trends before the visit instead of asking ‘how’s your weight?’

Asynchronous check-ins: Between monthly visits, patients can submit updates via secure message or app. Simple questions (‘Week 3 on new dose – any nausea?’) can be handled asynchronously in 2-3 minutes instead of scheduling a call.

Automated scheduling: Let patients book follow-ups directly via online scheduler. Reduces staff time on phone calls.

Template documentation: Build smart phrases or templates for common scenarios:

• ‘Pt reports mild nausea, improving with small frequent meals. Continuing current dose.’
• ‘Weight down 6 lbs since last visit. Tolerating 0.5mg semaglutide well. Increasing to 1mg today.’

This cuts charting time in half.

Group Support to Reduce One-on-One Burden

Monthly group sessions (via Zoom or similar) can cover:

• Nutrition tips
• Exercise strategies
• Managing side effects
• Motivational support

This provides patients with community and ongoing education without requiring one-on-one provider time. A health coach or RN can facilitate; psychiatrist drops in for Q&A if needed.

Patients love this – they get peer support and don’t feel isolated. You reduce the counseling load on individual visits.

Set Boundaries to Protect Your Schedule

1. Block specific times for GLP-1 patients rather than mixing them throughout your day. Example: Tuesday and Thursday afternoons are weight management; rest of week is psychiatric care. This mental segmentation helps prevent burnout.

2. Cap daily volume. Don’t book 12 GLP-1 consults in one day. Even brief visits are draining if stacked back-to-back. Aim for 4-6 per half-day max.

3. Use ‘office hours’ for patient questions instead of 24/7 portal access. Example: ‘I respond to messages Monday/Wednesday/Friday 12-1pm.’ This manages expectations and prevents constant interruptions.

4. Build in admin time. Schedule doesn’t need to be 100% patient visits. Block time for chart review, lab follow-up, and planning.

5. Take vacations. Seriously. Telehealth makes it easy to never stop working. Don’t fall into that trap. Close your schedule or have a backup provider cover emergencies.

When to Scale by Adding Providers

If you’re consistently booked out 3-4 weeks and turning away patients, consider:

Hiring an NP or PA (if allowed in your state) to handle routine follow-ups while you focus on initial evaluations and complex cases.

Partnering with another psychiatrist or physician to split the patient panel – you each handle certain days or patient types.

Building a group practice model where you supervise mid-levels who see most patients, and you handle oversight + complex cases. This is how many psychiatric clinics scale.

Key principle: Scale by leverage, not just by working more hours yourself. Your time is finite; systems and people give you leverage.

FAQ: What Psychiatrists Ask About GLP-1 Practices

Can I prescribe GLP-1s if I’m not board-certified in obesity medicine?

Yes. Any licensed physician (MD/DO) can prescribe GLP-1 medications for obesity within their scope of practice. Board certification in obesity medicine is not required – though some CME in obesity management or metabolic health is helpful for confidence and competence. Many psychiatrists start by treating medication-induced weight gain in their existing patients and build expertise from there.

What if I’m a PMHNP – can I do this?

It depends on your state. Psychiatric NPs can prescribe GLP-1s in most states, but often under physician collaboration:

• Full independent practice states (CA starting 2026, NY after 3,600 hours, IL with FPA) – yes, you can practice autonomously
• Reduced/restricted practice states (TX, PA, FL) – you’ll need a collaborating physician

Many telehealth platforms will pair you with a supervising physician if needed. Or partner directly with a psychiatrist colleague willing to oversee your GLP-1 protocols.

Do I need separate malpractice insurance for weight-loss prescribing?

Probably not a separate policy, but notify your current insurer. Prescribing for obesity falls under general medical practice. Most malpractice policies cover this, but it’s wise to inform your carrier you’re adding weight management services. They may ask about your protocols and training. Document that you’re following evidence-based guidelines (e.g. Endocrine Society or AACE obesity treatment guidelines).

How do I handle patients who want GLP-1s but don’t meet criteria?

Set clear eligibility criteria and communicate them:

• FDA-approved criteria: BMI ≥30, or BMI ≥27 with weight-related comorbidities (diabetes, hypertension, dyslipidemia, sleep apnea)
• Your practice policies (you might set stricter criteria – e.g. BMI ≥30 only, or require 6 months of documented lifestyle modification first)

If a patient doesn’t qualify, explain why and offer alternatives:

• Refer to dietitian or weight management program
• Discuss lifestyle modifications
• Revisit in 3-6 months if weight increases or new comorbidities develop

Don’t bend criteria just to grow volume. Inappropriate prescribing puts your license at risk and harms patients.

What about the shortage of GLP-1 medications?

GLP-1 supply has improved significantly since the 2022-2023 shortages, but occasional scarcity still happens. Best practices:

• Stay informed about current supply (check FDA drug shortage database)
• Have backup options – if Wegovy is unavailable, can prescribe Ozempic off-label, or use tirzepatide (Mounjaro/Zepbound) or liraglutide (Saxenda)
• Work with compounding pharmacies that produce semaglutide – but ensure they’re FDA-compliant (legitimate compounding pharmacies, not fly-by-night operations)
• Communicate with patients about potential supply issues upfront

How do I manage patients who experience mood changes on GLP-1s?

This is where your psychiatric expertise shines:

1. Screen proactively – use PHQ-9 or similar at each visit to track mood objectively

2. Educate patients that rapid weight loss can sometimes trigger mood changes (both positive and negative)

3. If patient reports new depression/anxiety:

• Assess severity (suicidal ideation? functional impairment?)
• Consider if it’s medication effect vs. independent mental health issue
• You can adjust psychiatric meds, add therapy referral, or in rare cases discontinue GLP-1 if mood change is severe
• The FDA found no causal link between GLP-1s and suicide, but remain vigilant

4. Document your assessment and decision-making – this protects you and ensures continuity of care

Can I prescribe GLP-1s to my existing psychiatric patients, or is that a conflict?

Not a conflict – it’s often ideal. Treating the whole patient is good medicine. Many psychiatrists:

• Prescribe GLP-1s to mitigate antipsychotic-induced weight gain
• Help patients with binge eating disorder using both therapy and medication
• Address obesity that worsens mood disorder outcomes

Just document clearly: separate the psychiatric visit from weight management visit (if billing matters), and ensure patient understands you’re wearing two hats (psychiatric prescriber + weight management prescriber). Get informed consent for both.

What’s a realistic revenue expectation from adding GLP-1 services?

Back-of-napkin math:

Scenario: Part-time GLP-1 practice (10 hours/week)

• See 20 follow-up patients/week (15-20 min each) at $100/visit = $2,000/week
• See 2-3 new patients/week at $200/visit = $500/week
• Total: $2,500/week = $10,000/month gross revenue from GLP-1 patients alone

Subtract platform fees (if using Klarity or similar – varies), staff costs, overhead. Net might be $6,000-7,000/month added to your practice income for 10 hours/week of work.

Scenario: Full-time GLP-1 practice (30 hours/week)

• Manage panel of 150-200 active patients (monthly follow-ups)
• Revenue: $15,000-20,000/month gross, $10,000-15,000/month net after expenses

These are conservative estimates with cash-pay model. Your actual numbers depend on pricing, patient volume, and efficiency.

How long does it take to ramp up patient volume?

If using a platform like Klarity: You could see first patients within days of onboarding. Ramping to 20-30 patients/month happens fast (1-2 months) if patient demand is high.

If marketing yourself (SEO, ads, referrals): Expect 3-6 months to build steady flow. SEO takes 6-12 months to pay off.

Word of mouth: Once you have 20-30 patients with good results, referrals accelerate. Weight loss is visible – patients talk about their providers.

Advice: Start slow (5-10 patients first month) to dial in your workflow. Then scale deliberately.

The Bottom Line: Is Adding GLP-1 Services Worth It?

For psychiatrists who:

• Want to diversify revenue beyond traditional psychiatric care
• Already see patients struggling with weight (especially medication-induced)
• Are comfortable with telehealth
• Value treating the whole person, not just one diagnosis
• Want a cash-pay service line that doesn’t depend on insurance

Adding GLP-1 weight management is one of the highest-ROI moves you can make right now.

The market is enormous and growing. Patient demand far exceeds supply. You have the clinical skills and patient relationships to deliver high-quality care. And unlike most psychiatric services, this is a cash-pay business model with straightforward economics.

But do it thoughtfully:

• Start with systems, not volume. Get your workflows dialed in before scaling.
• Use platforms like Klarity to handle patient acquisition efficiently instead of gambling on DIY marketing.
• Set boundaries early to protect against burnout.
• Stay compliant – know your state’s rules, document properly, work within your scope.

Done right, you can add $50,000-100,000+/year in net income working 10-15 hours/week on GLP-1 services – while genuinely improving patients’ lives by addressing both mental and metabolic health.

That’s not a side hustle. That’s a strategic practice expansion that positions you at the intersection of two massive healthcare trends: mental health telehealth and the obesity treatment revolution.

Ready to explore adding GLP-1 services without the marketing risk? Klarity Health connects psychiatrists with pre-qualified weight management patients through a pay-per-appointment model. Join our provider network to start seeing patients immediately – no upfront marketing spend, no subscription fees, just qualified patient flow when you have capacity.

References

1. Axios – ‘Just how many Americans are taking GLP-1s now’ (Fair Health data on GLP-1 usage trends), May 27, 2025. https://www.axios.com/2025/05/27/american-glp1-use-weight-loss-increasing

2. ConfectioneryNews – ‘GLP-1 drugs like Ozempic are reshaping health, diet and the food industry’ (estimates on US GLP-1 prevalence and market impact), October 20, 2025. https://www.confectionerynews.com/Article/2025/10/20/glp-1-drugs-like-ozempic-are-reshaping-health-diet-and-the-food-industry/

3. Time Magazine – ‘The Heavy Cost of Using Weight-Loss Drugs to Get Skinny’ (insurance coverage, patient out-of-pocket costs, and coverage barriers), August 22, 2025. https://time.com/7311517/cost-weight-loss-drugs-skinny/

4. Axios – ‘America’s doctors need more obesity medicine training’ (provider shortage, patient monitoring needs

Source:

• https://www.axios.com/2025/05/27/american-glp1-use-weight-loss-increasing#:~:text=More%20than%202,their%20original%20approved%20use
• https://www.confectionerynews.com/Article/2025/10/20/glp-1-drugs-like-ozempic-are-reshaping-health-diet-and-the-food-industry/#:~:text=GLP,real%20number%20according%20to%20Kim
• https://forum.schizophrenia.com/t/psychiatrists-recommend-ozempic/311318#:~:text=Drugs%20pharmanewsintel
• https://www.medicaldirectorco.com/texas-weight-loss-clinic-telehealth-compliance-guide/#:~:text=equivalent%20to%20in,FDA%2C%20pharmacy%2C%20and%20board%20alerts
• https://www.medicaldirectorco.com/texas-weight-loss-clinic-telehealth-compliance-guide/#:~:text=,with%20chart%20review%2C%20plus%20meetings
• https://www.singleaimhealth.com/news/nurse-practitioner-collaborative-agreement-templates-50-state-guide#:~:text=In%20Pennsylvania%2C%20Certified%20Registered%20Nurse,the%20CRNP%20and%20the%20collaborating
• https://www.wheel.com/state-telehealth-regulations/florida#:~:text=Are%20There%20Online%20Prescription%20Restrictions,for%20Telehealth%20in%20Florida
• https://time.com/7311517/cost-weight-loss-drugs-skinny/#:~:text=most%20insurances%20cover%20the%20medication,A%20recent%20Annals%20of%20Internal
• https://www.axios.com/2024/11/05/states-slow-to-cover-glp-1s-for-weight-loss#:~:text=What%20they%20found%3A%20In%20all%2C,a%20primary%20concern%2C%20KFF%20found
• https://time.com/7311517/cost-weight-loss-drugs-skinny/#:~:text=But%20these%20medications%20were%20originally,diabetes%2C%20weight%20loss%20treatment%20is